Apogee Therapeutics

Public

Waltham, MassachusettsBiotechhttps://www.apogeetherapeutics.com/

Last Round

IPO Announced

Jul 18, 2023

Total Funding Raised

$345M

Company Overview

Apogee Therapeutics is a biotechnology company developing innovative biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease, and related inflammatory and immunology conditions.

Sector

Biotech

AI Layer

Non-AI

Keywords

biotechnologybiotechmonoclonal antibodiesbiologic therapiesclinical-stage biotechdrug developmentatopic dermatitisasthma treatmenthalf-life extensioninflammatory diseasesCOPDchronic obstructive pulmonary diseasebiopharmaclinical trialsantibody engineering

Apogee Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Apogee Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Apogee Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
IPO Announced	Jul 18, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Michael Henderson

Chief Executive Officer at Apogee Therapeutics

Executive Team

Jane Pritchett Henderson

Chief Financial Officer

Executive Team

Apogee Therapeutics Investors

Notable investors and investment history

Apogee Therapeutics investors
Investor	Rounds
Jefferies	IPO
Guggenheim Securities	IPO
Wedbush	IPO
TD Cowen	IPO
Stifel Financial Corp.	IPO

View all Investors

Apogee Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Apogee Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersWaltham, Massachusetts

Employee Range300

Year Founded2022

Last FundingJul 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.